Literature DB >> 22745568

Structure - relaxivity relationships among targeted MR contrast agents.

Peter Caravan1, Zhaoda Zhang.   

Abstract

Paramagnetic gadolinium(III) complexes are widely used to increase contrast in magnetic resonance (MR) images. Contrast enhancement depends on the concentration of the gadolinium complex and on its relaxivity, an inherent property of the complex. Increased relaxivity results in greater image contrast or the ability to detect the contrast agent at a lower concentration. Increasing relaxivity enables imaging of abundant molecular targets.Relaxivity depends on the structure of the complex, kinetics of inner-sphere and second sphere water exchange, and on the rotational dynamics of the molecule. The latter, and in some cases the former, properties of the complex change when it is bound to its target. All of these properties can be rationally tuned to enhance relaxivitry. In this Microreview we summarize our efforts in understanding and optimizing the relaxivity of contrast agents targeted to serum albumin and to fibrin.

Entities:  

Year:  2012        PMID: 22745568      PMCID: PMC3381435          DOI: 10.1002/ejic.201101364

Source DB:  PubMed          Journal:  Eur J Inorg Chem        ISSN: 1434-1948            Impact factor:   2.524


  47 in total

1.  Development of a tumor-targeting MR contrast agent using the high-affinity folate receptor: work in progress.

Authors:  S D Konda; M Aref; M Brechbiel; E C Wiener
Journal:  Invest Radiol       Date:  2000-01       Impact factor: 6.016

2.  Multilocus binding increases the relaxivity of protein-bound MRI contrast agents.

Authors:  Zhaoda Zhang; Matthew T Greenfield; Marga Spiller; Thomas J McMurry; Randall B Lauffer; Peter Caravan
Journal:  Angew Chem Int Ed Engl       Date:  2005-10-21       Impact factor: 15.336

3.  The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates.

Authors:  Peter Caravan; Normand J Cloutier; Matthew T Greenfield; Sarah A McDermid; Stephen U Dunham; Jeff W M Bulte; John C Amedio; Richard J Looby; Ronald M Supkowski; William DeW Horrocks; Thomas J McMurry; Randall B Lauffer
Journal:  J Am Chem Soc       Date:  2002-03-27       Impact factor: 15.419

Review 4.  A review of 1H nuclear magnetic resonance relaxation in pathology: are T1 and T2 diagnostic?

Authors:  P A Bottomley; C J Hardy; R E Argersinger; G Allen-Moore
Journal:  Med Phys       Date:  1987 Jan-Feb       Impact factor: 4.071

5.  MR angiography of aortoiliac occlusive disease: a phase III study of the safety and effectiveness of the blood-pool contrast agent MS-325.

Authors:  Mathias Goyen; Mark Edelman; Pierre Perreault; Elaine O'Riordan; Hernan Bertoni; James Taylor; Daniel Siragusa; Melhem Sharafuddin; Emile R Mohler; Robert Breger; E Kent Yucel; Kohkan Shamsi; Robert M Weisskoff
Journal:  Radiology       Date:  2005-07-14       Impact factor: 11.105

6.  High relaxivity magnetic resonance imaging contrast agents. Part 1. Impact of single donor atom substitution on relaxivity of serum albumin-bound gadolinium complexes.

Authors:  Stéphane Dumas; Vincent Jacques; Wei-Chuan Sun; Jeffrey S Troughton; Joel T Welch; Jaclyn M Chasse; Heribert Schmitt-Willich; Peter Caravan
Journal:  Invest Radiol       Date:  2010-10       Impact factor: 6.016

7.  High-relaxivity magnetic resonance imaging contrast agents. Part 2. Optimization of inner- and second-sphere relaxivity.

Authors:  Vincent Jacques; Stéphane Dumas; Wei-Chuan Sun; Jeffrey S Troughton; Matthew T Greenfield; Peter Caravan
Journal:  Invest Radiol       Date:  2010-10       Impact factor: 6.016

8.  Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles.

Authors:  Patrick M Winter; Anne M Morawski; Shelton D Caruthers; Ralph W Fuhrhop; Huiying Zhang; Todd A Williams; John S Allen; Elizabeth K Lacy; J David Robertson; Gregory M Lanza; Samuel A Wickline
Journal:  Circulation       Date:  2003-10-13       Impact factor: 29.690

9.  Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility.

Authors:  Josef Vymazal; Elmar Spuentrup; Gerardo Cardenas-Molina; Andrea J Wiethoff; Michael G Hartmann; Peter Caravan; Edward C Parsons
Journal:  Invest Radiol       Date:  2009-11       Impact factor: 6.016

10.  Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging.

Authors:  Patrick M Winter; Shelton D Caruthers; Andrea Kassner; Thomas D Harris; Lori K Chinen; John S Allen; Elizabeth K Lacy; Huiying Zhang; J David Robertson; Samuel A Wickline; Gregory M Lanza
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

View more
  12 in total

1.  Binding of a dimeric manganese porphyrin to serum albumin: towards a gadolinium-free blood-pool T1 MRI contrast agent.

Authors:  Weiran Cheng; Tameshwar Ganesh; Francisco Martinez; Jolie Lam; Hyung Yoon; Robert B Macgregor; Timothy J Scholl; Hai-Ling Margaret Cheng; Xiao-an Zhang
Journal:  J Biol Inorg Chem       Date:  2014-01-10       Impact factor: 3.358

2.  Crosslinked shells for nano-assembled capsules: a new encapsulation method for smaller Gd3+-loaded capsules with exceedingly high relaxivities.

Authors:  Annah Farashishiko; Sally E Plush; Karley B Maier; A Dean Sherry; Mark Woods
Journal:  Chem Commun (Camb)       Date:  2017-06-08       Impact factor: 6.222

Review 3.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

4.  Gd(DOTAla): a single amino acid Gd-complex as a modular tool for high relaxivity MR contrast agent development.

Authors:  Eszter Boros; Miloslav Polasek; Zhaoda Zhang; Peter Caravan
Journal:  J Am Chem Soc       Date:  2012-11-16       Impact factor: 15.419

5.  Characterization of estrogen-receptor-targeted contrast agents in solution, breast cancer cells, and tumors in vivo.

Authors:  Adi Pais; Inbal Eti Biton; Raanan Margalit; Hadassa Degani
Journal:  Magn Reson Med       Date:  2012-08-10       Impact factor: 4.668

Review 6.  The importance of water exchange rates in the design of responsive agents for MRI.

Authors:  A Dean Sherry; Yunkou Wu
Journal:  Curr Opin Chem Biol       Date:  2013-01-17       Impact factor: 8.822

Review 7.  Enhancing magnetic resonance imaging with contrast agents for ultra-high field strengths.

Authors:  Akhila N W Kuda-Wedagedara; Matthew J Allen
Journal:  Analyst       Date:  2014-09-21       Impact factor: 4.616

8.  Structure-relaxivity relationships of serum albumin targeted MRI probes based on a single amino acid Gd complex.

Authors:  Eszter Boros; Peter Caravan
Journal:  J Med Chem       Date:  2013-02-19       Impact factor: 7.446

9.  Introductory Chemistry: A Molar Relaxivity Experiment in the High School Classroom.

Authors:  Anna C Dawsey; Kathryn L Hathaway; Susie Kim; Travis J Williams
Journal:  J Chem Educ       Date:  2013-07-09       Impact factor: 2.979

10.  Coupling fast water exchange to slow molecular tumbling in Gd3+ chelates: why faster is not always better.

Authors:  Stefano Avedano; Mauro Botta; Julian S Haigh; Dario L Longo; Mark Woods
Journal:  Inorg Chem       Date:  2013-07-10       Impact factor: 5.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.